359 filings
8-K
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
SC 13D/A
ATXI
Avenue Therapeutics Inc
17 Apr 24
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:05pm
4
ATXI
Avenue Therapeutics Inc
17 Apr 24
Change in insider ownership
4:05pm
8-K
ATXI
Avenue Therapeutics Inc
29 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2:41pm
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
8-K
rum4njsg
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
rrm1m5r xj7g8bl6r2
15 Mar 24
Other Events
7:15am
PRE 14C
orl385jg3dj175xzmz
8 Mar 24
Preliminary information
4:31pm
8-K
6h5tem1
8 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
rl78rwytcddlzny
23 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:17pm
EFFECT
gfd 7nbh8hsy1pbp
2 Feb 24
Notice of effectiveness
12:15am
424B3
ijopnq91h 502xu
2 Feb 24
Prospectus supplement
12:00am
CORRESP
r2889jqvuat7y pd
30 Jan 24
Correspondence with SEC
12:00am
DEF 14C
21hkrqvnnl k6s71ba
29 Jan 24
Information statement
8:00am
UPLOAD
xfmonr7cru ylh
29 Jan 24
Letter from SEC
12:00am
PRE 14C
8ywao5g7e9z
17 Jan 24
Preliminary information
5:05pm
8-K
rbxp04hommgcmkwit s8
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am
8-K
jqwo0zrju
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm